| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.7M | +21.8% |
| SG&A Expense | $2.0M | -2.4% |
| Operating Income | -$3.7M | -7.4% |
| Net Income | -$3.3M | -10.3% |
| EPS (Basic) | -$0.02 | +0.0% |
| EPS (Diluted) | -$0.02 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.6M | -36.6% |
| Current Assets | $5.7M | -36.4% |
| Total Assets | $5.7M | -36.4% |
| Current Liabilities | $710K | +6.7% |
| Total Liabilities | $3.7M | +1.2% |
| Stockholders' Equity | $2.0M | -62.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | -19.7% |
| Financing Cash Flow | -$411K | +0.0% |